作者: Junichi Shindoh , Ching-Wei D. Tzeng , Thomas A. Aloia , Steven A. Curley , Giuseppe Zimmitti
DOI: 10.1245/S10434-012-2864-7
关键词:
摘要: Background Patients with colorectal liver metastases (CLM) are increasingly treated preoperative chemotherapy. Chemotherapy associated injury is postoperative hepatic insufficiency (PHI) and mortality. The adequate minimum future remnant (FLR) volume in patients extensive chemotherapy remains unknown.